BCLS Fund IV Investments reported a 17.43% stake in Kailera Therapeutics KLRA · 22,583,268 sh

Trade details

Type: 5% stake report
Report: 13D
Stake: 17.43%
Last report: First report
Shares held: 22,583,268 sh
Class: Common Stock, $0.00001 par value per share
Stock: Kailera Therapeutics KLRA
Holder: BCLS Fund IV Investments
Event date: 26/04/16
Filed: 26/04/23

First 5%+ report · 17.43% stake

Kailera Therapeutics trades, last 26 weeks

What else happened in Kailera Therapeutics around then

Filed or reported within 30 days of the trade day · 03/17~05/16

BCLS Fund IV Investments's other 5% stake reports

No other trades yet.